Angiotensin II type 1 receptor mediates partially hyposmotic-induced increase of I (Ks) current in guinea pig atrium

Pflugers Arch. 2009 Sep;458(5):837-49. doi: 10.1007/s00424-009-0669-8. Epub 2009 Apr 29.

Abstract

A repolarizing conduction in the heart augmented by hyposmotic or mechanically induced membrane stretch is the slow component of delayed rectifier K(+) current (I (Ks)). I (Ks) upregulation is recognized as a factor promoting appearance of atrial fibrillation (AF) since gain-of-function mutations of the channel genes have been detected in congenital AF. Mechanical stretch activates angiotensin II type 1 (AT(1)) receptor in the absence of its physiological ligand angiotensin II. We investigated the functional role of AT(1) receptor in I (Ks) enhancement in hyposmotically challenged guinea pig atrial myocytes using the whole-cell patch-clamp method. In atrial myocytes exposed to hyposmotic solution with osmolality decreased to 70% of the physiological level, I (Ks) was enhanced by 84.1%, the duration of action potential at 90% repolarization (APD(90)) was decreased by 16.8%, and resting membrane potential was depolarized (+4.9 mV). The hyposmotic-induced effects on I (Ks) and APD(90) were significantly attenuated by specific AT(1) receptor antagonist candesartan (1 and 5 muM). Pretreatment of atrial myocytes with protein tyrosine kinase inhibitors tyrphostin A23 and A25 suppressed but the presence of tyrosine phosphatase inhibitor orthovanadate augmented hyposmotic stimulation of I (Ks). The above results implicate AT(1) receptor and tyrosine kinases in the hyposmotic modulation of atrial I (Ks) and suggest acute antiarrhythmic properties of AT(1) antagonists in the settings of stretch-related atrial tachyarrhythmias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Angiotensin II / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds
  • Cell Shape / drug effects
  • Cell Shape / physiology
  • Electrophysiological Phenomena / drug effects
  • Electrophysiological Phenomena / physiology*
  • Enzyme Inhibitors / pharmacology
  • Guinea Pigs
  • Heart Atria / cytology
  • Heart Atria / metabolism*
  • Hypotonic Solutions / pharmacology
  • Immunoglobulin G / immunology
  • Immunoglobulin G / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology
  • Osmolar Concentration
  • Potassium / metabolism*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Receptor, Angiotensin, Type 1 / immunology
  • Receptor, Angiotensin, Type 1 / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Tetrazoles / pharmacology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Biphenyl Compounds
  • Enzyme Inhibitors
  • Hypotonic Solutions
  • Immunoglobulin G
  • Receptor, Angiotensin, Type 1
  • Tetrazoles
  • Angiotensin II
  • Protein-Tyrosine Kinases
  • Potassium
  • candesartan